Swiss Medica Inc.: Leading Texas Pain Management Institute Latest O24 Customer.

Business Editors

TORONTO--(BUSINESS WIRE)--March 10, 2004

Grant Johnson, President and COO, is pleased to announce that the University of Body Wellness, has joined Swiss Medica's (OTCBB:SWME) growing distribution and retail expansion in the United States.

University of Body Wellness ("UBW") is a center for advanced studies located in the north Dallas metroplex. UBW employs Massage Therapists who specialize in all types of massage and bodywork modalities to include deep tissue, trigger point, myofascial release, manual lymphatic drainage and sports massage. The UBW grad-internship program provides an avenue for newly registered Massage Therapists to acquire advanced training while working in a teaching environment under the guidance of the industry's leading instructors and seasoned therapists.

UBW has a product research department that continually evaluates the latest massage products. Perhaps the most well received product is the O24 Pain Relief oil. UBW therapists performed a product evaluation on several clients with symptoms ranging from lower back spasms to muscle strains. The results were overwhelming for both the therapists and the clients," said Steve Weismann, CEO of UBW.

Mr. Weismann further explains, "Therapeutic lotions must deliver immediate comfort and relief to the client while providing a smooth and consistent application by the therapist. O24 has exceeded our expectations. We are excited to be the first company in our market to incorporate O24 into our clinic and advanced studies program."

Johnson had this to say, "We are very encouraged by this development for several reasons. The fact that a therapy school has brought in O24 as a core product in treating their clients is very exciting. UBW has roughly 200 new graduates each year that certainly will increase O24's exposure. We are also pleased that UBW is so impressed with O24 they have committed to becoming our representatives to the therapy and pain management practitioners in the great State of Texas."

About Swiss Medica Inc.

Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com and www.O24zone.com.

Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.